Man facing possible prison time after administering CT contrast without license, proper training

Matt O'Connor | | Health Imaging | Imaging Contrast

A suburban Chicago man is facing up to 12 years in prison after he allegedly injected an imaging contrast agent into a patient without proper training or licensure, the Daily Herald reported Tuesday.

Omayr K. Niazi, 41, is charged with aggravated battery, forgery and wire fraud and may face 4-12 years in prison. He is being held on $100,000 bail as of May 4, the news outlet reported.

Back on Nov. 23, Niazi, who holds a pharmacy technician license, injected a female patient with contrast for a CT scan at Hope Imaging and Medical Center located in Hoffman Estates, Illinois. After the contrast was administered, the patient had a negative reaction in her arm and later called the police, according to the Daily Herald.

An investigation by the local authorities found Niazi wasn’t trained or certified to perform CT scans and discovered he submitted false credentials and reimbursement claims to insurance companies without authorization.

Hope Imaging did not immediately respond to a Health Imaging request for comment.

Read the entire story below.

Pharmacy tech charged with aggravated battery at Hoffman Estates imaging center

""
Matt O'Connor

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Related Content

GE Healthcare investing $138 million to bolster contrast supply
New GBCA uses 60% less gadolinium
Could synthetic images replace the need for contrast?
Standard contrast protocols may be 'overdosing' women with the imaging agent
Multidose contrast injectors could increase waste in some radiology departments
New protocol addresses contrast allergies in patients with suspected stroke

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.